The global AI in Precision Medicine Market was valued at USD 1.80 billion in 2023 and is projected to reach USD 18.27 billion by 2032, growing at a CAGR of 29.37% over 2024–2032. AI is rapidly integrating into genomics, drug research, and patient-centric healthcare, driving market growth.

AI in Precision Medicine provides personalized health solutions using advanced algorithms, big data analytics, and genomic information. Collaboration between pharmaceutical companies, AI technology providers, and medical institutions is improving new drug development and treatment efficiency.

In 2023, North America led the AI in Precision Medicine market with roughly 46% market share, driven by sophisticated healthcare infrastructure and broad use of precision medicine solutions. Europe emerged as the fastest-growing region with a projected CAGR of 36.13%, fueled by government funding and rising adoption of personalized medicine.

Recent developments include Tempus AI reporting a fourth-quarter loss of USD 0.18 per share in February 2025, attributing increased expenses to an expanded sales force. Exscientia also entered a strategic collaboration with Tempus in November 2023 to advance biomarker-driven therapeutic development using a data-first approach. The AI in Precision Medicine market is projected to reach USD 1.80 billion by 2023 and USD 18.27 billion by 2032, with a CAGR of 29.37% from 2024 to 2032. Key segments include components, technology, deployment, therapeutic areas, applications, and end-users. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

For more information on AI in Precision Medicine market analysis and outlook, visit https://www.snsinsider.com/reports/ai-in-precision-medicine-market-6030. SNS Insider is a leading market research and consulting agency providing clients with current, accurate market data and insights to make informed decisions in a changing environment. Contact [email protected] for customization or inquiries.

Read more at GlobeNewswire: AI in Precision Medicine Market to Reach USD 18.27 Billion